Allelic loss at the neurofibromatosis type 1 (NF1) gene locus is frequent in desmoplastic neurotropic melanoma

Human Genetics

Volumn 107, Issue 4, 2000, Pages 357-361

  Gutzmer, Ralf ^a   Herbst, Rudolf ^a   Mommert, Susanne ^a   Kiehl, Peter ^a   Matiaske, Frank ^a   Rütten, Arno ^b   Kapp, Alexander ^a   Weiss, Jürgen ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Dermatopathologische Gemeinschaftspraxis   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROFIBROMIN;

ALLELISM; ARTICLE; CONTROLLED STUDY; EXON; FIBROMA; GENE; GENE LOCUS; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MELANOMA; NEUROFIBROMATOSIS; NEUROTROPISM; PRIORITY JOURNAL; TISSUE DIFFERENTIATION;

ALLELES; CHROMOSOME BANDING; DNA, NEOPLASM; GENES, NEUROFIBROMATOSIS 1; HUMANS; LOSS OF HETEROZYGOSITY; MELANOMA; POLYMORPHISM, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 0033757791     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004390000374     Document Type: Article

References (31)

1. A PCR-based test for a polymorphism within the human NF1 gene
2. Mutations in the neurofibromatosis 1 gene in sporadic malignant melanoma cell lines
3. Aberrant regulation of ras proteins in tumour cells from type 1 neurofibromatosis patients
4. New evidence for a mutation hotspot in exon 37 of the NF1 gene
5. Desmoplastic melanoma
6. Desmoplastic neurotropic melanoma. A clinicopathological analysis of 28 cases
7. Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene
8. Desmoplastic malignant melanoma (a rare variant of spindle cell melanoma)
9. Abnormal regulation of mammalian p21ras contributed to malignant tumour growth in von Recklinghausen (type 1) neurofibromatosis
10. A rapid and non-radioactive PCR based assay for the detection of allelic loss in human gliomas
11. Cutaneous melanoma in a patient with neurofibromatosis: A case report and review of the literature
12. Chromosome 17 allelic loss and NF1-GRD mutations do not play a significant role as molecular mechanisms leading to melanoma tumourigenesis
13. Identification of the neurofibromatosis type 1 gene product
14. Genetic and biochemical evidence that haploinsufficiency of the NF1 tumour suppressor gene modulates melanocyte and mast cell fates in vivo
15. Inactivation of the NF1 gene in human melanoma and neuroblastoma cell lines without impaired regulation of GTP
16. Suppression of a human colon cancer cell line by introduction of an exogenous NF1 gene
17. Somatic mutations in the neurofibromatosis 1 gene in human tumours
18. NF1 inactivation cooperates with N-Ras in in vivo lymphogenesis activating Erk by a mechanism independent of its Ras-GTPase accelerating activity
19. Induction of melanogenic abnormalities in NF1+/- mutant mice by DMBA
20. Ras signalling and NF1
21. Characterisation of two different nonsense mutations C6792A and C6792G, causing skipping of exon 37 in the NF1 gene
22. Characterisation of inherited and sporadic mutations in neurofibromatosis type-1
23. Max interacting protein 1: Loss of heterozygosity is frequent in desmoplastic melanoma
24. Two current nonsense mutations and a 4 bp deletion in a quasi-symmetric element in exon 37 of the NF1 gene
25. Identification of NF1 mutations in both alleles of a dermal neurofibroma
26. NF1: A prevalent cause of tumourigenesis in human cancers?
27. Desmoplastic malignant melanoma
28. NF1 gene mutations in neuroblastoma
29. Characterization of germline mutations in the neurofibromatosis type 1 (NF1) gene
30. Characterization of six mutations in exon 37 of neurofibromatosis type 1 gene
31. Malignant and benign tumours in patients with neurofibromatosis 1 in a defined Swedish populations